Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. - Test2 - elhamkhani - TriplyDB

Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.

Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.

http://www.wikidata.org/entity/Q37388643

about

Patient-level costs of major cardiovascular conditions: a review of the international literature Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data.Determining initial and follow-up costs of cardiovascular events in a US managed care population.Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis.Medical costs associated with type 2 diabetes complications and comorbidities.Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK.Determinants of inpatient costs of angina pectoris, myocardial infarction, and heart failure in a university hospital setting in Turkey.Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review.Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia.Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study.Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis.Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.

P2860

Q28076912-BEBE56C5-8BA4-4FA3-94BC-EC7524C503C5 Q30972356-27DF15AF-F009-4FA0-8C71-375D7340DCAD Q33848530-7D9D3EC6-5E86-49C2-B186-AB0092EFCE67 Q35004835-53C92C4D-14DD-4E78-994C-EB1479E0C432 Q35110549-84C0786E-06D0-459E-AF25-50BB43F8121F Q35894735-DA43916D-D515-4624-AB8F-A7C56AB2DC5B Q36327173-EC699127-58D5-4836-AF3E-3C3166AF50F3 Q36926126-D5F42763-6144-4AC2-AECC-010EEABF6A51 Q37177894-6E424A11-300D-4194-B7C4-DACA7CE73948 Q37680408-517086AE-6B7D-41EF-AC4E-F6E081945787 Q38396629-810C346B-888C-4A40-9204-FB154BEFC891 Q40810206-61B89FF2-654D-485B-BCA5-2C54A6D14B32 Q41618016-9384E085-A956-4709-AA5D-A26A0C81F541 Q51345288-D3E1B79C-0555-4045-9DFF-790B0E4062C4 Q55207460-F29ECA9F-4349-49A1-AEDB-BF111E3D749D

P2860

Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.

http://www.wikidata.org/entity/Q37388643

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Incremental cardiovascular cos ...... n the US managed-care setting.

@en

Incremental cardiovascular cos ...... n the US managed-care setting.

@nl

type

label

Incremental cardiovascular cos ...... n the US managed-care setting.

@en

Incremental cardiovascular cos ...... n the US managed-care setting.

@nl

prefLabel

Incremental cardiovascular cos ...... n the US managed-care setting.

@en

Incremental cardiovascular cos ...... n the US managed-care setting.

@nl

P1433

Q37388643-A8868CFC-EB53-4D49-A0E8-DFC8A489C0D1

P1476

Q37388643-7D493247-682F-4AB3-9717-5228D683EF1D

P2093

Q37388643-39518210-B585-4D05-9D4B-5984C467A1C1

Q37388643-4E22EC4B-2273-487C-AE94-C210FA3C2A2C

Q37388643-7A373FB8-69A3-4BA6-B7C5-5F62D74210BB

Q37388643-C772BB53-8DD3-4E23-B562-DDF02E35AE7E

Q37388643-D8755DB0-AF40-4FFF-ABC8-BEEFC4406A50

P2860

Q37388643-26551FDB-F719-4DCA-B34A-D17500DE826A

Q37388643-3823F9E3-757A-43D0-ABB4-60750FFF9AE8

Q37388643-5040A6A9-6175-4B8A-8DFC-41CBE5194F2A

Q37388643-599546AF-FFC1-4561-82BB-880A35009DBB

Q37388643-61902424-CC4E-4EB9-8472-7910DDD72E84

Q37388643-6FDEBBC7-14EC-4247-BE9A-8A4DA2616BEA

Q37388643-76B767E4-DD6F-4FAE-8359-0F593BB68C43

Q37388643-795661D4-8F5E-4032-8F91-F3A66CF99120

Q37388643-850BF3E9-4917-4963-BEC0-34E18BDC62EE

Q37388643-A3C432CF-03DE-45D3-B7FC-56CBDDD4084B

P2888

Q37388643-0D08E0BD-A6D0-45EB-B2D3-BE6EC355E576

P304

Q37388643-0FE4A2B5-3964-42E2-8122-6924320A85B5

P31

Q37388643-67026178-839B-4804-8293-3BBE47943FA9

P356

Q37388643-93745948-6758-4CDB-BFFB-6D802B7261F7

P407

Q37388643-8C33669F-376E-45DB-AEAD-BC8198836D05

P478

Q37388643-99AFA4E0-15F6-4C64-AE6E-95F85C7CCBA9

P577

Q37388643-DB1E2E7B-B1D5-47FF-8438-118E6072F6B8

P5875

Q37388643-8863E0BA-67DD-4B9D-BE05-BF99F4235B73

P6179

Q37388643-42D9A4B9-C728-4C9E-915F-8BD619C070D7

P698

Q37388643-A1930FD6-816B-44AB-9414-0DDEB08DB45C

P921

Q37388643-20D43A83-9A41-4961-A570-40A2CC103158

Q37388643-A3B1AC75-8722-444D-BFE2-3B7EF375758C

P932

Q37388643-41BFB899-170A-481B-B04A-B9499BD859FD

P356

P1433

Cardiovascular Diabetology

P1476

Incremental cardiovascular cos ...... n the US managed-care setting.

@en

P2093

Allyson DeLorenzo

http://www.w3.org/2001/XMLSchema#string

Larry Z Liu

http://www.w3.org/2001/XMLSchema#string

Prafulla S Girase

http://www.w3.org/2001/XMLSchema#string

Richard H Chapman

http://www.w3.org/2001/XMLSchema#string

Robert J Straka

http://www.w3.org/2001/XMLSchema#string

P2860

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event.

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Economic costs of diabetes in the U.S. In 2007.

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes.

P2888

P304

53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-8-53

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26837966

http://www.w3.org/2001/XMLSchema#string

P6179

1036439156

http://www.w3.org/2001/XMLSchema#string

P698

19781099

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2762466

http://www.w3.org/2001/XMLSchema#string